Incidence of Secondary Malignancies after Hodgkin Lymphoma Treatment in Lebanon
The number of patients with Hodgkin ’s lymphoma that are being cured and have long term remission is increasing exponentially with time, this is due to newer anti-neoplastic drugs and improved radiotherapy. On the other hand, these new treatments involve higher risks for the development of secondary malignancies.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Marcel Massoud, Tarek Bou Assy, Riwa Sakr, Layale Rached, Fadi Nasr, Charbel Yazbeck, Fouad Kerbage, Georges Chahine Source Type: research